REVIEW PAPER
Leukoaraiosis – new concepts and modern imaging
 
More details
Hide details
 
Publication date: 2018-02-15
 
 
Pol J Radiol, 2018; 83: 76-81
 
KEYWORDS
ABSTRACT
Leukoaraiosis is a pathological appearance of the brain white matter, which has long been believed to be caused by perfusion disturbances within the arterioles perforating through the deep brain structures. Due to its complex etio­pathogenesis and clinical relevance, leukoaroisosis has been investigated in a multitude of studies. As regards the clinical implications of leukoaraiosis, this neuroimaging finding is strongly related to ischaemic stroke, unfavourable course of ischaemic stroke in the acute phase, worse long-term outcomes, and cognitive disturbances. The morpholo­gical changes in the deep white matter that are collectively described as leukoaraiosis, despite a seemingly homogenous appearance, probably resulting from various causes, such as atherosclerosis, neurotoxic factors including radiation therapy and chemotherapy, and neuroinfections. Based on our experience and recent literature, we present the symptomatology of leukoaroisosis and similar radiological abnormalities of the cerebral white matter.
REFERENCES (16)
1.
Zagrajek MM, Pokryszko-Dragan A. Charakterystyka i obraz kliniczny leukoarajozy. Udar Mózgu 2005; 7: 56-60.
 
2.
Ben-Assayag E, Mijajlovic M, Shenhar-Tsarfaty S, et al. Leukoaraiosis is a chronic atherosclerotic disease. Scientific World J 2012; 2012: 532141.
 
3.
Helenius J, Tatlisumak T. Treatment of leukoaraiosis: a futuristic view. Current Drug Targets 2007; 8: 839-845.
 
4.
O’Sullivan M. Leukoaraiosis. Pract Neurol 2008; 8: 26-38.
 
5.
Rościszewska-Żukowska I, Kwolek A, Kruk W, Cichocka I. Występowanie leukoarajozy u pacjentów z udarem mózgu hospitalizowanych w oddziale udarowym. Prz Med Uniw Rzesz Inst Leków 2013; 3: 288-297.
 
6.
Mijajlović MD, Pavlović AM, Mirković MM, Šternić N. Connection between leukoaraiosis and ischemic stroke. Curr Top Neurol Psychiatr Relat Discip 2011; 19: 41-47.
 
7.
Kearney-Schwartz A, Rossignol P, Bracard S, et al. Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints. Stroke 2009; 40: 1229-1236.
 
8.
Scheltens P, Erkinjunti T, Leys D, et al. White matter changes on CT and MRI: an overview of visual rating scales. Eur Neurol 1998; 39: 80-89.
 
9.
Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010; 9: 689-701.
 
10.
Shi J, Hao K, Qi P, et al. Confirmation of the abnormal lipid metabolism as a risk factor for the disease of leukoaraiosis. Saudi J Biol Sci 2017; 24: 508-513.
 
11.
Zhang Z, Ren W, Shao B, et al. Leukoaraiosis is associated with worse short-term functional and cognitive recovery after minor stroke. Neurol Med Chir (Tokyo) 2017; 57: 136-143.
 
12.
Wadia RS, Ghiya SK, Singh J, et al. Clinical correlates of leukoaraiosis: A study of 175 patients. Ann Indian Acad Neurol 2016; 19: 478‐481.
 
13.
Gilberti N, Gamba M, Premi E, et al. Leukoaraiosis is a predictor of futile recanalization in acute ischemic stroke. J Neurol 2017; 264: 448-452.
 
14.
Lamot U, Avsenik J, Šega S, Šurlan Popovič K. Presence of central veins and susceptibility weighted imaging for evaluating lesions in multiple sclerosis and leukoaraiosis. Mult Scler Relat Disord 2017; 13: 67-72.
 
15.
Wei W, Xia Z, Gao H, et al. Correlation of retinopathy with leukoaraiosis in patients with anterior circulation infarcts. J Clin Neurosci 2016; 33: 105-110.
 
16.
Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013; 12: 822-838.
 
Journals System - logo
Scroll to top